13 results
Multiple Myeloma - Treatment Algorithm
a) Newly Diagnosed Myeloma: Transplant Eligible
b) Newly Diagnosed Myeloma: Transplant Ineligible

doi: 10.1038/s41408-020-00359-2

#Multiple
Myeloma - Treatment Algorithm ... a) Newly Diagnosed ... Eligible b) Newly Diagnosed ... #management #hematology ... #oncology
Stroke Evaluation and Management Algorithm

Clinical suspicion of stroke (BE FAST)
 • Balance loss
 • Eyes: vision
Evaluation and Management ... Algorithm Clinical ... #Algorithm #diagnosis ... #differential #neurology ... #CVA
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... Malignancy #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology ... #Oncology
Stroke - Differential Diagnosis Algorithm and Management
Hemorrhagic:
 • Intracerebral: HTN, Cerebral Amyloid Angiopathy, Trauma, Bleeding Diathesis,
- Differential Diagnosis ... Algorithm and Management ... SCVMCMed #Stroke #CVA ... #Algorithm #management ... #neurology #treatment
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... Suggested treatment algorithm ... #Anticoagulation ... #Management #Hematology ... #Oncology
Indications for tPA in Stroke:
 • Clinical diagnosis of ischemic stroke
 • Measurable neurologic deficit
 •
: • Clinical diagnosis ... • Therapeutic anticoagulation ... #tPA #Stroke #cva ... #management #neurology
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Thrombosis and Management ... Algorithm #Anticoagulation ... Breakthrough #Thrombosis #Algorithm ... Extension #VTE #DVT #Hematology ... #Management #Diagnosis
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
permeability Diagnosis ... prevention (statin for CVA ... #rheumatology # ... cerebritis #diagnosis ... #management #treatment
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
b) CHF c) CVA ... event, follow ACC algorithm ... Anticoagulation ... medical and surgical management ... stratification #diagnosis
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Treatment algorithms ... patients with no CV ... Hydroxyurea + anticoagulation ... #diagnosis #management ... #hematology